Frontiers in Medicine (Sep 2023)
Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis
- Emilia Roy-Vallejo,
- Emilia Roy-Vallejo,
- Sara Fernández De Córdoba-Oñate,
- Pablo Delgado-Wicke,
- Ana Triguero-Martínez,
- Ana Triguero-Martínez,
- Nuria Montes,
- Nuria Montes,
- Rosa Carracedo-Rodríguez,
- Nelly Zurita-Cruz,
- Ana Marcos-Jiménez,
- Ana Marcos-Jiménez,
- Amalia Lamana,
- José María Galván-Román,
- José María Galván-Román,
- Gonzalo Villapalos García,
- Gonzalo Villapalos García,
- Pablo Zubiaur,
- Pablo Zubiaur,
- Marianela Ciudad,
- Laura Rabes,
- Marta Sanz,
- Carlos Rodríguez,
- Almudena Villa,
- Jesús Álvarez Rodríguez,
- Celeste Marcos,
- Julia Hernando,
- Paula Díaz-Fernández,
- Paula Díaz-Fernández,
- Francisco Abad,
- Francisco Abad,
- Francisco Abad,
- Ignacio de los Santos,
- Ignacio de los Santos,
- Ignacio de los Santos,
- Diego A. Rodríguez Serrano,
- Rosario García-Vicuña,
- Rosario García-Vicuña,
- Carmen Suárez Fernández,
- Carmen Suárez Fernández,
- Carmen Suárez Fernández,
- Rosa P. Gomariz,
- Cecilia Muñoz-Calleja,
- Cecilia Muñoz-Calleja,
- Cecilia Muñoz-Calleja,
- Elena Fernández-Ruiz,
- Elena Fernández-Ruiz,
- Elena Fernández-Ruiz,
- Isidoro González-Álvaro,
- Isidoro González-Álvaro,
- Laura Cardeñoso,
- Laura Cardeñoso,
- the PREDINMUN-COVID Group
Affiliations
- Emilia Roy-Vallejo
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Emilia Roy-Vallejo
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Sara Fernández De Córdoba-Oñate
- Rheumathology Department, Hospital Universitario La Princesa, Madrid, Spain
- Pablo Delgado-Wicke
- Molecular Biology Unit, Hospital Universitario La Princesa, Madrid, Spain
- Ana Triguero-Martínez
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Ana Triguero-Martínez
- Rheumathology Department, Hospital Universitario La Princesa, Madrid, Spain
- Nuria Montes
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Nuria Montes
- Rheumathology Department, Hospital Universitario La Princesa, Madrid, Spain
- Rosa Carracedo-Rodríguez
- Molecular Biology Unit, Hospital Universitario La Princesa, Madrid, Spain
- Nelly Zurita-Cruz
- Microbiology Department, Hospital Universitario La Princesa, Madrid, Spain
- Ana Marcos-Jiménez
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Ana Marcos-Jiménez
- Immunology Department, Hospital Universitario La Princesa, Madrid, Spain
- Amalia Lamana
- Cell Biology Department, Facultad de Biología, Universidad Complutense, Madrid, Spain
- José María Galván-Román
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- José María Galván-Román
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Gonzalo Villapalos García
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Gonzalo Villapalos García
- Clinical Pharmacology Department, Hospital Universitario La Princesa, Instituto Teófilo Hernando, Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Pablo Zubiaur
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Pablo Zubiaur
- Clinical Pharmacology Department, Hospital Universitario La Princesa, Instituto Teófilo Hernando, Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Marianela Ciudad
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Laura Rabes
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Marta Sanz
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Carlos Rodríguez
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Almudena Villa
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Jesús Álvarez Rodríguez
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Celeste Marcos
- Pneumology Department, Hospital Universitario La Princesa, Madrid, Spain
- Julia Hernando
- 0Anesthesiology Department, Hospital Universitario La Princesa, Madrid, Spain
- Paula Díaz-Fernández
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Paula Díaz-Fernández
- Immunology Department, Hospital Universitario La Princesa, Madrid, Spain
- Francisco Abad
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Francisco Abad
- Clinical Pharmacology Department, Hospital Universitario La Princesa, Instituto Teófilo Hernando, Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Francisco Abad
- 1Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain
- Ignacio de los Santos
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Ignacio de los Santos
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Ignacio de los Santos
- 2Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Diego A. Rodríguez Serrano
- 3Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain
- Rosario García-Vicuña
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Rosario García-Vicuña
- Rheumathology Department, Hospital Universitario La Princesa, Madrid, Spain
- Carmen Suárez Fernández
- Internal Medicine Department, Hospital Universitario La Princesa, Madrid, Spain
- Carmen Suárez Fernández
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Carmen Suárez Fernández
- 4Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Rosa P. Gomariz
- Cell Biology Department, Facultad de Biología, Universidad Complutense, Madrid, Spain
- Cecilia Muñoz-Calleja
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Cecilia Muñoz-Calleja
- Immunology Department, Hospital Universitario La Princesa, Madrid, Spain
- Cecilia Muñoz-Calleja
- 4Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Elena Fernández-Ruiz
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Elena Fernández-Ruiz
- Molecular Biology Unit, Hospital Universitario La Princesa, Madrid, Spain
- Elena Fernández-Ruiz
- 4Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Isidoro González-Álvaro
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Isidoro González-Álvaro
- Rheumathology Department, Hospital Universitario La Princesa, Madrid, Spain
- Laura Cardeñoso
- Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
- Laura Cardeñoso
- Microbiology Department, Hospital Universitario La Princesa, Madrid, Spain
- the PREDINMUN-COVID Group
- DOI
- https://doi.org/10.3389/fmed.2023.1215246
- Journal volume & issue
-
Vol. 10
Abstract
IntroductionSARS-CoV-2 viral load has been related to COVID-19 severity. The main aim of this study was to evaluate the relationship between SARS-CoV-2 viremia and SNPs in genes previously studied by our group as predictors of COVID-19 severity.Materials and methodsRetrospective observational study including 340 patients hospitalized for COVID-19 in the University Hospital La Princesa between March 2020 and December 2021, with at least one viremia determination. Positive viremia was considered when viral load was above the quantifiable threshold (20 copies/ml). A total of 38 SNPs were genotyped. To study their association with viremia a multivariate logistic regression was performed.ResultsThe mean age of the studied population was 64.5 years (SD 16.6), 60.9% patients were male and 79.4% white non-Hispanic. Only 126 patients (37.1%) had at least one positive viremia. After adjustment by confounders, the presence of the minor alleles of rs2071746 (HMOX1; T/T genotype OR 9.9 p < 0.0001), rs78958998 (probably associated with SERPING1 expression; A/T genotype OR 2.3, p = 0.04 and T/T genotype OR 12.9, p < 0.0001), and rs713400 (eQTL for TMPRSS2; C/T + T/T genotype OR 1.86, p = 0.10) were associated with higher risk of viremia, whereas the minor alleles of rs11052877 (CD69; A/G genotype OR 0.5, p = 0.04 and G/G genotype OR 0.3, p = 0.01), rs2660 (OAS1; A/G genotype OR 0.6, p = 0.08), rs896 (VIPR1; T/T genotype OR 0.4, p = 0.02) and rs33980500 (TRAF3IP2; C/T + T/T genotype OR 0.3, p = 0.01) were associated with lower risk of viremia.ConclusionGenetic variants in HMOX1 (rs2071746), SERPING1 (rs78958998), TMPRSS2 (rs713400), CD69 (rs11052877), TRAF3IP2 (rs33980500), OAS1 (rs2660) and VIPR1 (rs896) could explain heterogeneity in SARS-CoV-2 viremia in our population.
Keywords